Literature DB >> 2968887

Progression of proteinuria in type 1 and type 2 diabetes.

M E Cooper1, A Frauman, R C O'Brien, E Seeman, R M Murray, G Jerums.   

Abstract

A longitudinal study evaluating the time course of the transition from normal to microalbuminuria, and then on to macroalbuminuria, was made over a mean period of 7 years in a cohort of 52 patients with Type 1 diabetes and 61 patients with Type 2 diabetes. Transient episodes of micro- and macroalbuminuria were often observed before the ultimate development of persistent Albustix-positive proteinuria. The transition from normal to microalbuminuria and from micro- to macroalbuminuria was characterized by rises in renal albumin clearance accompanied by lesser rises in total proteinuria. Seven patients with Type 1 and 12 with Type 2 diabetes showed evidence of progression, the interval for the transition from normal to macroalbuminuria varying from 3 to 5 years. In Type 1 diabetic patients, the development of micro- and macroalbuminuria was associated with a decline in renal function and a rise in systolic blood pressure without a significant change in blood glucose control. In Type 2 diabetic patients, the development of microalbuminuria was associated with a small decline in renal function but no change in blood pressure or blood glucose control. It is concluded that the transition from normal to micro- and on to macroalbuminuria may be more rapid then previously reported and varies considerably among individuals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968887     DOI: 10.1111/j.1464-5491.1988.tb01006.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Integrating albuminuria and GFR in the assessment of diabetic nephropathy.

Authors:  George Jerums; Sianna Panagiotopoulos; Erosha Premaratne; Richard J MacIsaac
Journal:  Nat Rev Nephrol       Date:  2009-07       Impact factor: 28.314

Review 2.  Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Authors:  K L Goa; M Haria; M I Wilde
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  Microalbuminuria and nephropathy in insulin dependent diabetes mellitus.

Authors:  F M Campbell
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

4.  Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.

Authors:  A Schmitz; M Vaeth; C E Mogensen
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

5.  Early markers of the renal complications of insulin dependent diabetes mellitus.

Authors:  D M Gibb; D Dunger; M Levin; V Shah; C Smith; T M Barratt
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

6.  Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.

Authors:  R G Nelson; D J Pettitt; H R Baird; M A Charles; Q Z Liu; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

7.  Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.

Authors: 
Journal:  BMJ       Date:  1991-01-26

8.  Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.

Authors:  H Kapelrud; H J Bangstad; K Dahl-Jørgensen; K Berg; K F Hanssen
Journal:  BMJ       Date:  1991-09-21

Review 9.  Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.

Authors:  M A Weber; M R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jul-Aug       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.